Peer-influenced content. Sources you trust. No registration required. This is HCN.
Human Reproduction
In SCRaTCH-OFO, live birth rates were 64% with endometrial scratching and 57% without it among patients with unexplained infertility and favorable natural-conception prognosis. The difference was not statistically significant, and enrollment fell short.
Obstetrics & Gynecology October 14th 2026
Healthline
Mayim Bialik reports prolonged gastrointestinal symptoms after one dose of an unnamed GLP-1 medication taken for autoimmune symptoms. Her account describes individual intolerance, not the frequency of severe reactions or evidence of autoimmune benefit.
Endocrinology, Diabetes, Metabolism October 14th 2026
MDLinx
Experts discussing rising breast cancer diagnoses cite both incidence increases and improved detection, alongside persistent concerns about diagnostic delays. The commentary does not establish that more patient-centered care explains the increase.
Gynecologic Oncology October 14th 2026
Annals of Internal Medicine
ACP places estrogen-based therapy first in its pharmacologic pathway for menopausal vasomotor symptoms, with nonhormonal alternatives for contraindications or intolerance. Recommendation strength and evidence certainty vary, and long-term safety evidence remains limited.
Family Medicine/General Practice October 14th 2026
News Medical
Personalized models using wearable data forecast sedentary bouts in women with chronic pelvic pain, primarily endometriosis. Simpler models performed comparably to deep learning, but benefits from prediction-guided movement prompts remain untested.
Psychiatrist.com
A single-day inhaled mebufotenin regimen produced rapid, sustained symptom reductions through day 8 in 10 patients with postpartum depression, but the uncontrolled trial provides an early clinical signal rather than comparative efficacy evidence.
Clinical Pharmacology October 9th 2026